United States spent $162 million on remdesivir development but holds no patents, review finds,

The drug fizzled against Ebola in a clinical trial in Africa but showed promise against coronaviruses. The largest share of the $162 million was for clinical …, The drug fizzled against Ebola in a clinical trial in Africa but showed promise against coronaviruses. The largest share of the $162 million was for clinical …, Read More

Scroll to Top